Probiotic or Fiber for GLP-1 Bloating? Full Brand Matrix

Best GLP-1 Gut-Support Products for Bloating and Constipation: A Probiotic and Fiber Brand Matrix

No product in this matrix has been clinically tested to address both GLP-1-related bloating and constipation together; the two symptoms may involve partly different mechanisms, a stomach that empties more slowly versus a colon that moves more slowly. This matrix lines up 11 probiotic and fiber brands, WonderBiotics included, by strain or fiber type, starting dose, tolerability, and daily cost, so you can match the product to whichever symptom is actually bothering you.

Why Bloating and Constipation on a GLP-1 Aren't Necessarily the Same Problem

GLP-1 receptors sit throughout the gut, and activating them slows gastric emptying, a mechanism plausibly tied to early fullness, nausea, and bloating. In a trial of women with obesity and PCOS on semaglutide 1.0 mg weekly, four-hour stomach retention after a solid meal reached 37% at 12 weeks in the semaglutide group (up from about 7% at baseline) versus 0% in the placebo group at 12 weeks (P=0.002); at 12 weeks, median half-emptying time was 171 minutes in the semaglutide group versus 118 minutes in the placebo group¹.

Constipation is thought to run on a different, lower-GI track: altered colonic transit, and possibly reduced food, fluid, or fiber intake as appetite drops, though the source behind that second point documents these as general constipation risk factors rather than GLP-1-specific mechanisms². What's better documented is the symptom pattern: in a post-hoc, pooled analysis of the STEP 1 through 3 trials, constipation affected 24.2% of people on semaglutide 2.4 mg, and its prevalence plateaued earlier, around week 10, than nausea, diarrhea, and vomiting, which each peaked around week 20 before declining; constipation also lasted longer once it started, a median of 47 days versus 35 days on placebo³. The two symptoms can occur in the same treatment period, but a product built to feed gut bacteria or add stool bulk isn't automatically built to counter a slower stomach, and vice versa. That's why this page uses a matrix instead of naming one overall winner.

How This Matrix Works

Every product below is scored on the same four questions: which symptom it's positioned and evidenced for, what's inside it (strain or fiber type), what the label says to start with, and what it tends to cost per day at that starting dose. WonderBiotics makes two of the 11 products here, Probiotics for Gut Health and Daily Fiber Mix; the sections below identify finished-formula trial evidence separately from ingredient-level evidence for every brand, including ours.

The Probiotic and Fiber Brand Matrix

Retail prices for Metamucil and Benefiber were checked against the specific listings cited below in late August and early September 2026; both products showed different prices across other retailer listings checked the same week, so treat the ranges above as rough estimates rather than a fixed number^15,16.

Evidence by Product

Probiotics

WonderBiotics Probiotics for Gut Health centers its bloating-and-comfort positioning on B. lactis HN019, paired with a multi-enzyme blend and 11 other strains at 60 billion CFU total. Across three human trials, HN019 has shown positive results on gut transit time and bowel-movement frequency, with the clearest benefit in people who started with three or fewer bowel movements a week^17,18. The most recent trial, in 229 adults over 8 weeks, didn't find a significant difference on its main bowel-frequency measure, but people taking HN019 reported less bloating and abdominal pain than the placebo group¹⁹. These three trials were funded by the ingredient's manufacturers (Fonterra and Danisco for the first, DuPont for the second, Danisco China for the third)^17,18,19. The finished 12-strain WonderBiotics formula hasn't been tested as a whole; the evidence above applies to HN019 as an ingredient, and the matrix pairs this product with a fiber option for readers whose main complaint is hard, infrequent stools.

Align's single strain, B. longum 35624, has two randomized trials behind it from overlapping, industry-linked investigator groups (both include O'Mahony, Kiely, and Shanahan as authors), each showing benefit on bloating and abdominal pain or discomfort at a different dose: a 362-woman trial, sponsored by Procter & Gamble's Health Sciences Institute with at least one P&G-affiliated author, found the mid-dose (10⁸ CFU) beat placebo and both other doses on its primary pain-and-discomfort endpoint²⁰; a smaller 77-person trial found benefit at a higher dose (10¹⁰ CFU) on bloating, distension, and pain across most treatment weeks²¹. Neither trial's dose matches the current label's guaranteed shelf-life potency of 10 million CFU exactly. Neither trial enrolled GLP-1 users or was designed around constipation.

Seed's DS-01 has a published, peer-reviewed, placebo-controlled trial on a finished, multi-strain formula for bloating and gas in generally healthy adults who weren't selected for GLP-1 use: 350 adults with self-reported bloating and digestive discomfort were randomized, with 219 providing evaluable data at week 6 (the primary analysis required only one adherent post-baseline week, and the final two timepoints used last-observation-carried-forward for missing data). The full 24-strain, 53.6-billion-AFU formula significantly improved a GI quality-of-life score (primary endpoint, P<0.05) and a combined bloating-and-gas score (secondary endpoint, P<0.01) over 6 weeks²². Seed Health funded the study through a grant; trial operations were performed independently by a third-party research operator. Two authors are Seed employees or shareholders, and two more, including one who is separately an employee of Increnovo, serve as advisors to Seed²².

Culturelle Digestive Daily's label sticks to occasional gas, bloating, and diarrhea and doesn't claim to help constipation, which matters if regularity is your main goal. Ritual pairs two well-studied individual strains (LGG and BB-12) with a bacteriophage prebiotic and a tributyrin postbiotic inside a delayed-release capsule; the brand references a company study on this specific combination but doesn't publish methods, results, or a citable paper.

Fiber

WonderBiotics Daily Fiber Mix combines Fibersol (a soluble corn fiber chemically related to, but not the same tested product as, the wheat dextrin below), PHGG, and psyllium with FOS and polydextrose in one 6 g sachet. Lab fermentation testing of wheat dextrin, PHGG, and inulin (not Fibersol, psyllium, or FOS) found PHGG ferments more slowly and produces less gas than inulin, while wheat dextrin produced the least gas of the three²³. Psyllium is separately classified as nonfermentable rather than slow-fermenting, a different mechanism for tolerability²⁴. FOS belongs to the fructan family, which tends to ferment quickly once it reaches the colon. The blend mixes fibers with different fermentation profiles rather than being uniformly slow, consistent with the label's own guidance to expect some adjustment gas in the first week or two and to start at one sachet a day.

Psyllium, the fiber in Metamucil and ColonBroom, has the strongest bowel-frequency data of any fiber type here: a 2022 systematic review and meta-analysis of trials in adults with chronic constipation found fiber overall raised weekly bowel movements meaningfully, and psyllium showed an even larger increase in its own subgroup, though results varied a lot from trial to trial²⁴. Those psyllium trials generally used more psyllium per day than a single Metamucil packet provides, and the same review found that fiber's frequency benefit held up mainly at the higher end of the doses tested²⁴, worth knowing since one packet falls well under that range. The review also found a significant increase in flatulence severity across fiber types, based on a small number of trials²⁴, a signal that gas can increase with fiber supplementation without proving every fiber type here raises gas equally.

A 2013 in vitro fermentation study, funded by Novartis Consumer Health (Benefiber's manufacturer at the time, with a co-author who was a Novartis employee), found wheat dextrin produced the least gas of the fibers it tested in a lab fermentation vessel²³. That's a lab measurement of gas production, not a human bloating trial; standalone human evidence on wheat dextrin's effect on bowel frequency is thinner than psyllium's. A 2022 randomized trial of PHGG, the fiber WonderBiotics' blend also uses, in 52 long-term care residents found no significant difference in bowel frequency versus a water-only control; laxative use decreased significantly at weeks 3 and 4²⁵.

Supergut GLP-1 Daily Support markets a 6-to-7-gram stick pack of oat beta-glucan, resistant potato starch, and green banana starch with mechanism-based language about supporting the body's own GLP-1 signaling. The company's own published trial tested a different product: a 15-gram-fiber, 15-gram-protein meal-replacement shake in people with type 2 diabetes, which improved a diabetes-distress score and HbA1c but never directly measured GLP-1 itself²⁵. That trial doesn't transfer cleanly to the lower-dose stick pack sold today. PGX Daily's glucomannan and Metamucil or ColonBroom's psyllium both work by forming a viscous gel in the gut, which is why their labels require gradual titration and a full glass of water with every dose; a 1986 case report tied glucomannan tablets taken without enough water to esophageal obstruction²⁶.

Fiber and GLP-1 Safety Considerations

GLP-1 drugs slow gastric emptying and, based on their receptor distribution throughout the gut, are thought to reduce peristalsis and alter the migrating motor complex that regulates fasting gut motility. A 2025 case report described a woman with a prior history of small bowel obstruction who developed recurrent obstruction after starting semaglutide; the authors reported a temporal association and discussed GLP-1 receptor activation as a possible contributor, not as an established cause²⁷. Separately, at the population level, the evidence on GLP-1 drugs and intestinal obstruction is mixed: one study found a modestly higher hospitalization rate for obstruction versus another diabetes drug class (HR 1.69)²⁸, while a larger, more recent Scandinavian cohort study found no confirmed increase in risk²⁹. Neither of those two cohort studies measured gastric emptying or gut motility directly; they looked at hospitalization and diagnosis rates.

Use viscous, gel-forming fibers, psyllium and glucomannan specifically, with a full glass of water every time, start at the label's lowest dose, and add only one new probiotic or fiber product at a time so you can tell what's causing what. PHGG and Fibersol don't form the same kind of viscous gel and aren't tied to the same hydration warnings. Severe abdominal pain, persistent vomiting, or an inability to pass gas or stool at all are signs of a possible bowel obstruction, not ordinary constipation; Mayo Clinic lists those together as reasons to seek care right away rather than adding another supplement³⁰.

How to Use the Matrix

If bloating and post-meal fullness are your main complaint, especially if it started or worsened right after a dose increase, look at how each product is actually built. Seed DS-01 is the one brand here with a published, peer-reviewed placebo-controlled trial on its finished formula for bloating and gas. WonderBiotics Probiotics for Gut Health takes a different approach: 12 ingredient-level strains built around HN019, paired with a multi-enzyme blend aimed at everyday post-meal digestion, a routine many GLP-1 users are adjusting to as their diet changes. A fiber that leans nonfermentable or slow-fermenting, like Benefiber or psyllium, is a reasonable pairing with either one over a fructan-heavy fiber, though no cited trial has tested these specific combinations, particularly not in GLP-1 users.

If infrequent or effortful bowel movements are the main problem, fiber has the better track record: a psyllium-based product (Metamucil or ColonBroom) has the strongest frequency data here, though the trials behind that result generally used more psyllium per day than a single Metamucil packet provides. WonderBiotics Daily Fiber Mix is an option if you want psyllium alongside other fibers in one sachet. Adding a probiotic as a second layer, or spacing new products a week or two apart, is a practical way to isolate what's causing a symptom, not a sequencing strategy any cited trial has tested. If diet and fiber alone aren't enough after a reasonable trial, our guide to probiotic, fiber, and magnesium options for GLP-1 constipation covers when a short course of magnesium fits into that routine, and our step-by-step relief guide and long-term prevention checklist go deeper on pacing.

For more on why the symptom shows up in the first place, see our companion guides on why semaglutide causes constipation and does semaglutide cause gas and bloating. If you're weighing a specific brand from the matrix above against WonderBiotics, see the detailed comparisons: WonderBiotics vs Align, WonderBiotics vs Seed DS-01, WonderBiotics vs Culturelle Digestive Daily, WonderBiotics vs ColonBroom, and WonderBiotics vs Ritual Synbiotic+.

When to Call Your Doctor Instead of Reaching for a Supplement

New or worsening abdominal pain, a hard or swollen abdomen that doesn't improve, vomiting, or going days without passing stool or gas are signs this has moved past a supplement problem³⁰. NIDDK's list of constipation causes includes low fiber intake and dehydration alongside several medical conditions and medications², but a change in your usual bowel habits that's new, persistent, or paired with unintended weight loss or blood in the stool deserves a medical evaluation regardless of age. Don't stop or adjust a prescribed GLP-1 dose on your own to manage bloating or constipation; talk to the prescriber first.

If you're pregnant, breastfeeding, immunocompromised, or managing a chronic GI condition such as inflammatory bowel disease or a prior bowel obstruction, check with your doctor before starting any new probiotic or fiber product, including WonderBiotics Probiotics for Gut Health or Daily Fiber Mix.

References

1. Jensterle M, Ferjan S, Ležaič L, Sočan A, Goričar K, Zaletel K, Janez A. Semaglutide delays 4-hour gastric emptying in women with PCOS and obesity. Diabetes Obes Metab. 2023;25(4):975-984. PMID 36511825
2. NIDDK: Symptoms & Causes of Constipation
3. Wharton S, Calanna S, Davies M, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24(1):94-105. PMID 34514682
4. WonderBiotics Probiotics for Gut Health
5. Align Probiotic 24/7 Digestive Support
6. Seed DS-01 Daily Synbiotic
7. Culturelle Digestive Daily Probiotic Capsules
8. Ritual Synbiotic+ for Gut Health
9. WonderBiotics Daily Fiber Mix
10. DailyMed: Metamucil Psyllium Fiber Supplement Therapy for Regularity, Orange Flavor (setid 12d030b0)
11. Benefiber Powder - Original
12. ColonBroom Psyllium Husk Powder Colon Cleanser, Strawberry, Walmart product listing; Premium weight-management claim registered as NCT06023082 (open-label, no control group; participants reportedly not told the brand/product name) and summarized at ColonBroom Premium clinical study page
13. Supergut GLP-1 Daily Support
14. Natural Factors PGX Daily Ultra Matrix Softgels, 750 mg
15. Metamucil Psyllium Fiber Supplement, Orange Smooth, Real Sugar, 30 Packets, Walmart product listing (checked early September 2026; other retailer listings the same week showed different prices)
16. Benefiber Daily Prebiotic Fiber Powder, 17.6 oz, Walmart product listing (checked early September 2026; other retailer listings the same week showed different prices)
17. Waller PA, Gopal PK, Leyer GJ, et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011;46(9):1057-1064. PMID 21663486
18. Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation. Gut Microbes. 2018;9(3):236-251. PMID 29227175
19. Cheng J, Gao C, Ala-Jaakkola R, et al. Eight-Week Supplementation With Bifidobacterium lactis HN019 and Functional Constipation: A Randomized Clinical Trial. JAMA Netw Open. 2024;7(10):e2436888. PMID 39356506
20. Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EMM. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101(7):1581-1590. PMID 16863564
21. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128(3):541-551. PMID 15765388
22. Allegretti JR, Kassam Z, Kelly CR, et al. A Randomized, Placebo-Controlled Trial Evaluating Multi-Species Synbiotic Supplementation for Bloating, Gas, and Abdominal Discomfort. Nutrients. 2026;18(2):255. PMID 41599868
23. Noack J, Timm D, Hospattankar A, Slavin J. Fermentation Profiles of Wheat Dextrin, Inulin and Partially Hydrolyzed Guar Gum Using an In Vitro Digestion Pretreatment and In Vitro Batch Fermentation System Model. Nutrients. 2013;5(5):1500-1510. PMID 23645025
24. van der Schoot A, Drysdale C, Whelan K, Dimidi E. The effect of fiber supplementation on chronic constipation in adults: an updated systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2022;116(4):953-969. PMID 35816465
25. Frias JP, Lee ML, Carter MM, et al. A microbiome-targeting fibre-enriched nutritional formula is well tolerated and improves quality of life and haemoglobin A1c in type 2 diabetes. Diabetes Obes Metab. 2023;25(5):1203-1212. PMID 36594522
26. Henry DA, Mitchell AS, Aylward J, et al. Glucomannan and risk of oesophageal obstruction. BMJ. 1986;292(6520):591-592. PMID 3004635
27. Jones M, Cappola JJ. GLP-1 Receptor Agonists in Diabetes and Obesity: A Case Report and Review of Bowel Obstruction Risks and Management. Cureus. 2025;17(4):e81891. PMID 40342457
28. Faillie JL, Yin H, Yu OHY, et al. Incretin-based drugs and risk of intestinal obstruction among patients with type 2 diabetes. Clin Pharmacol Ther. 2022. PMID 34587280
29. Ueda P, Wintzell V, Melbye M, et al. Use of DPP4 Inhibitors and GLP-1 Receptor Agonists and Risk of Intestinal Obstruction: Scandinavian Cohort Study. Clin Gastroenterol Hepatol. 2024. PMID 37716613
30. Mayo Clinic: Intestinal obstruction - Symptoms & causes